Likewise, increase of inflammation was also detected shortly after Photofrin-PDT, as indicated by elevated levels of serum IL-6, a pro-inflammatory cytokine, in patients with esophageal squamous cell carcinoma (ESCC) at one week after treatment, but this declined soon after two weeks [67]. Here, IL6 is linked to esophageal squamous cell carcinoma.